Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies
J. S. Terry, L. B. Anderson, M. S. Scherman, C. E. McAlister, R. Perera, T. Schountz, B. J. Geiss
This study develops and characterizes mouse monoclonal antibodies specific to SARS-CoV-2 nucleocapsid protein, tested using ELISA, western blot, and immunofluorescence.
bioRxiv · Sep 3, 2020Microbiology